Somatropin Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Somatropin Injection (injection) from Novo Nordisk, Inc. with status To Be Discontinued. The shortage was first posted on 11/14/2025.
Shortage Details
- Status
- To Be Discontinued
- Company
- Novo Nordisk, Inc.
- Package NDC
- 0169-7703-21
- Dosage Form
- Injection
- Presentation
- Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21)
- Initial Posting
- 11/14/2025
- Revised Date